CARDIOVASCULAR RISK PROFILES OF MONOTHERAPY VS. COMBINATION THERAPY IN TYPE 2 DIABETES. (2025). Review Journal of Neurological & Medical Sciences Review, 3(7), 140-147. https://doi.org/10.63075/7swvcz45